Related Experiment Video

Updated: Aug 11, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

Revisiting quality standards in hemodialysis vascular access: where is the bar?

Alison Thomas1

  • 1Hemodialysis, St Michael Hospital, Toronto, Ontario. thomasal@smh.toronto.on.ca

CANNT Journal = Journal ACITN
|February 24, 2006
PubMed

Insights

Optimizing hemodialysis vascular access, particularly arteriovenous fistulas, is crucial for treatment effectiveness. This study examines challenges and strategies, including catheter management, to improve patient outcomes in hemodialysis.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Nursing

Background:

  • Vascular access performance directly impacts hemodialysis adequacy and patient outcomes.
  • Clinical guidelines exist for optimal hemodialysis vascular access.
  • Canada shows suboptimal arteriovenous (AV) fistula utilization and increased central venous catheter (CVC) use.

Purpose of the Study:

  • To address barriers to AV fistula prevalence and promote fistula creation.
  • To emphasize the importance of meeting vascular access blood flow standards for hemodialysis adequacy.
  • To explore thrombolytic therapy for managing central venous catheter (CVC) malfunction.

Main Methods:

  • Case study approach.
  • Review of existing standards for vascular access, including CVC function.
  • Discussion of clinical practice and potential therapeutic strategies.

Main Results:

  • Lower than recommended AV fistula rates and increasing CVC use in Canada present challenges.
  • Hemodialysis nursing staff play a key role in improving fistula rates.
  • Meeting blood flow standards is critical for all vascular accesses.

Conclusions:

  • Addressing barriers to AV fistula creation and use is essential.
  • Maintaining optimal vascular access function, including CVCs, is paramount for hemodialysis adequacy.
  • Thrombolytic therapy may offer a solution for catheter-related complications.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...